Targeted Protein Degradation to Explore the Potential of Histone Lysine Deacetylases (HDACs) in Inflammation
Time: 3:45 pm
day: Conference Day Two
Details:
- Non-selective small molecule inhibitors of Histone lysine deactylases (HDACs) are clinically applied in oncology
- HDACs are enzymes that have catalytic functions but they also play a role in protein-protein interactions
- Application of the PROTAC technology enable targeting the non-enzyme functions of HDACs
